$2.23T
Total marketcap
$73.57B
Total volume
BTC 56.23%     ETH 8.99%
Dominance
us

ResMed Inc. RSMDF Stock

$16.99   0.000000%
Add to favorites
Market Cap
$24.65B
LOW - HIGH [24H]
$20.06 - $20.06
VOLUME [24H]
$13.00
P/E Ratio
16.33
Earnings per share
$1.04
ISIN
AU000000RMD6
Price   Prediction

ResMed Inc. Price Chart

Sorry, that's all we've gotfor now...

ResMed Inc. RSMDF Financial and Trading Overview

ResMed Inc. stock price 16.99 USD
Previous Close 16.99 USD
Open 20.06 USD
Bid 16.38 USD x 10000
Ask 21.37 USD x 10000
Day's Range 20.06 - 20.06 USD
52 Week Range 11.85 - 28.25 USD
Volume 13 USD
Avg. Volume 88 USD
Market Cap 29.1B USD
Beta (5Y Monthly) 0.782
PE Ratio (TTM) 19.288462
EPS (TTM) 1.04 USD
Forward Dividend & Yield 0.24 (1.40%)
Ex-Dividend Date May 13, 2026
1y Target Est N/A

RSMDF Valuation Measures

Enterprise Value 9.04B USD
Trailing P/E 19.288462
Forward P/E 48.92683
PEG Ratio (5 yr expected) 1
Price/Sales (ttm) 5.2544994
Price/Book (mrq) 1.7927121
Enterprise Value/Revenue 1.633
Enterprise Value/EBITDA 4.265

Trading Information

ResMed Inc. Stock Price History

Beta (5Y Monthly) 0.782
52-Week Change -22.77%
S&P500 52-Week Change 24.48%
52 Week High 28.25 USD
52 Week Low 11.85 USD
50-Day Moving Average 20.19 USD
200-Day Moving Average 24.31 USD

RSMDF Share Statistics

Avg. Volume (3 month) 88 USD
Avg. Daily Volume (10-Days) 36 USD
Shares Outstanding 1.45B
Float 576.64M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 8.39%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.33
Trailing Annual Dividend Yield 13.71%
5 Year Average Dividend Yield N/A
Payout Ratio 0.22469999
Last Split Factor 2:1

Financial Highlights

Fiscal Year

Fiscal Year Ends June 30, 2025
Most Recent Quarter (mrq) March 31, 2026
Next Fiscal Year End June 30, 2026

Profitability

Profit Margin 27.43%
Operating Margin (ttm) 35.32%
Gross Margin 62.18%
EBITDA Margin 38.27%

Management Effectiveness

Return on Assets (ttm) 14.71%
Return on Equity (ttm) 25.24%

Income Statement

Revenue (ttm) 5.54B USD
Revenue Per Share (ttm) 9.48 USD
Quarterly Revenue Growth (yoy) 10.80%
Gross Profit (ttm) 3.44B USD
EBITDA 2.12B USD
Net Income Avi to Common (ttm) 1.52B USD
Diluted EPS (ttm) 1.04
Quarterly Earnings Growth (yoy) 9.19%

Balance Sheet

Total Cash (mrq) 1.66B USD
Total Cash Per Share (mrq) 2.86 USD
Total Debt (mrq) 843.17M USD
Total Debt/Equity (mrq) 12.99 USD
Current Ratio (mrq) 3.008
Book Value Per Share (mrq) 11.18975

Cash Flow Statement

Operating Cash Flow (ttm) 1.89B USD
Levered Free Cash Flow (ttm) 1.45B USD

Profile of ResMed Inc.

Country United States
State CA
City San Diego
Address 9001 Spectrum Center Boulevard
ZIP 92123
Phone 858-836-5000
Website https://www.resmed.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 10600

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Q&A For ResMed Inc. Stock

What is a current RSMDF stock price?

ResMed Inc. RSMDF stock price today per share is 16.99 USD.

How to purchase ResMed Inc. stock?

You can buy RSMDF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for ResMed Inc.?

The stock symbol or ticker of ResMed Inc. is RSMDF.

Which industry does the ResMed Inc. company belong to?

The ResMed Inc. industry is Medical Instruments & Supplies.

How many shares does ResMed Inc. have in circulation?

The max supply of ResMed Inc. shares is 1.45B.

What is ResMed Inc. Price to Earnings Ratio (PE Ratio)?

ResMed Inc. PE Ratio is 16.33653800 now.

What was ResMed Inc. earnings per share over the trailing 12 months (TTM)?

ResMed Inc. EPS is 1.04 USD over the trailing 12 months.

Which sector does the ResMed Inc. company belong to?

The ResMed Inc. sector is Healthcare.

Select currency